The Technical Analyst
Select Language :
OncoSec Medical Inc [ONCS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

OncoSec Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

OncoSec Medical Inc is listed at the  Exchange

31.87% $0.277

America/New_York / 23 jun 2023 @ 16:00


OncoSec Medical Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1.653 mill
EPS: -20.31
P/E: -0.0136
Earnings Date: Dec 11, 2020
SharesOutstanding: 5.96 mill
Avg Daily Volume: 2.13 mill
RATING 2023-06-23
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Neutral
Price To Book: Strong Sell
QUARTER GROWTHS
4/211/222/223/224/221/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0136 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.0136 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.169 - 0.385

( +/- 38.96%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-02-09 Delaversano Robert J Sell 40 Common Stock
2022-11-04 Delaversano Robert J Sell 283 Common Stock
2022-10-07 Foster Spahr Stephany Buy 50 000 Stock Option (right to buy)
2022-10-07 Foster Spahr Stephany Buy 0
2022-08-05 Delaversano Robert J Sell 284 Common Stock
INSIDER POWER
99.42
Last 87 transactions
Buy: 13 356 389 | Sell: 519 303

Forecast: 01:40 - $0.276

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.277 (31.87% )
Volume 51.30 mill
Avg. Vol. 2.13 mill
% of Avg. Vol 2 406.96 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for OncoSec Medical Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for OncoSec Medical Inc

RSI

Intraday RSI14 chart for OncoSec Medical Inc

Last 10 Buy & Sell Signals For ONCS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            OncoSec Medical Inc

ONCS

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey.

Last 10 Buy Signals

Date Signal @
DAOUSDMar 29 - 01:54$1.742
BONDUSDMar 29 - 01:534.97
NOSUSDMar 29 - 01:494.05
FOLDUSDMar 29 - 01:4824.92
PENDLEUSDMar 29 - 01:434.34
SANTOSUSDMar 29 - 01:437.66
OGUSDMar 29 - 01:435.90
ENSUSDMar 29 - 01:4122.01
TWTUSDMar 29 - 01:40$1.420
KSMUSDMar 29 - 01:38$48.53

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.